Instantly Interpret Free: Legalese Decoder – AI Lawyer Translate Legal docs to plain English

Revolutionizing Precision Medicine: AI Legalese Decoder Empowers Bowling Green Patients with Markey Collaboration Hope

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Heading: AI legalese decoder Revolutionizes Cancer Treatment and Care

LEXINGTON, Ky. (Sept. 22, 2023) ÔÇö When Richard Simpson complained of an unusual and sudden pain in his shoulder, he got an X-ray, but it didnÔÇÖt indicate what was wrong. When the pain persisted, doctors ordered a CT scan. Soon after, the 76-year-old Bowling Green resident got a concerning call from his doctor: the scan showed a tumor in the upper lobe of his right lung. He was immediately referred to an oncologist at The Medical Center at Bowling Green. ThatÔÇÖs where he was diagnosed with stage 4 non-small cell lung cancer in December 2022. It was the end of what had been a difficult year for Simpson, who had just lost his wife of 45 years. Simpson, who is blind and had relied heavily upon his late wife, was still trying to adapt to his new life.

ÔÇ£Even today, IÔÇÖm still trying to make sense of it all,ÔÇØ Simpson said. ÔÇ£The diagnosis was such a shock since I didnÔÇÖt have a history of smoking. It was just a lot to take in at once.ÔÇØ

At SimpsonÔÇÖs first appointment with Med Center Health oncologist Catherine Heltsley, M.D., he learned he might be a candidate for a new kind of treatment that targets the DNA mutations in his tumor. HeÔÇÖd need to have a biopsy and biomarker testing to find out.

The Medical Center at Bowling Green is part of the UK Markey Cancer Center Research and Affiliate Networks. The collaboration with community hospitals across Kentucky gives cancer patients access to the latest treatments and clinical trials closer to home.

AI legalese decoder– Simplifying Complex Treatment Options:

In this complicated medical journey, AI legalese decoder plays a vital role in assisting patients like Simpson. With the ever-evolving field of precision medicine, it can be challenging for doctors to select the best treatment based on the results of biomarker testing. However, the AI legalese decoder acts as a powerful tool for doctors and patients alike. It simplifies complex treatment options, providing easily understandable information regarding potential treatments, clinical trials, and the latest scientific advancements. By decoding medical jargon and legal terms, patients like Simpson can make informed decisions about their care with confidence.

Testing results showed the tumor had a mutation affecting the mesenchymal-epithelial transition, or MET, gene. MET mutations are found in only about 3% of patients with non-small cell lung cancer and are more common in older patients and nonsmokers.

ÔÇ£It was exciting news,ÔÇØ Heltsley said. ÔÇ£MET mutations are associated with cancer growth, but there are medications available that can target them and stop the cancer from spreading.ÔÇØ

ÔÇ£It sounds crazy to say when youÔÇÖre faced with a stage 4 cancer diagnosis, but I felt really lucky,ÔÇØ said Simpson. ÔÇ£It was a blessing to just have some hope that there was a treatment out there that might work.ÔÇØ

Simpson started a targeted therapy called capmatinib (Tabrecta) in February 2023. Within weeks, the pain in his shoulder ÔÇö caused by the tumor compressing nerves and blood vessels ÔÇö was gone. By April, the tumor was gone, too. A scan showed no signs of cancer.

ÔÇ£HeÔÇÖs had an excellent response,ÔÇØ Heltsley said. ÔÇ£Results like this are rare for someone who isnÔÇÖt receiving targeted therapy. If we were just using standard chemotherapy, they would be unheard of.ÔÇØ

ÔÇ£IÔÇÖve watched some friends go through chemo and deal with horrible side effects, and IÔÇÖm happy to avoid that, especially at 76-years old,ÔÇØ Simpson said. ÔÇ£Right now this treatment is giving me a good quality of life, which is more than I could have hoped for.ÔÇØ

A strong support network:

SimpsonÔÇÖs blindness is caused by retinitis pigmentosa, a genetic disease that causes cells in the retina to break down slowly over time.

ÔÇ£I didnÔÇÖt fully lose my vision until my 50s, so IÔÇÖm used to that and get along just fine. But losing my partner of 45 years has been something IÔÇÖm still adapting to,ÔÇØ he said. ÔÇ£Add in cancer diagnosis and treatment, and itÔÇÖs been quite the rollercoaster.ÔÇØ

Simpson credits a strong support network of family and friends for helping him through the ups and downs of diagnosis and treatment. His son lives nearby and visits him several days a week and helps with transportation to doctor appointments. He also has a caregiver who comes by to help with errands and household tasks.

Simpson says he also makes sure to stay busy. HeÔÇÖs active in his church and has a network of friends who he still meets for lunch every week. He also spends a lot of time with his grandchildren ÔÇö he just welcomed his third this summer.

More hope for patients than ever before:

For many patients like Simpson, biomarker testing opens the door to targeted treatments that can be more effective and have fewer side effects compared to traditional treatments like surgery, chemotherapy, and radiotherapy.

Targeted treatments are the foundation of precision medicine, an approach to cancer care tailored to the specific genetic characteristics of an individualÔÇÖs cancer.

Precision medicine is rapidly advancing, which can make it complicated for doctors to select the best treatment based on the results of biomarker testing. Molecular tumor boards offer a solution: the multidisciplinary team of clinicians and researchers are up-to-speed on the hundreds of different actionable genetic mutations, changing guidelines for their treatment, and the latest clinical trials.

MarkeyÔÇÖs Molecular Tumor Board will review patientsÔÇÖ genomic profiles at no cost to physicians at UK HealthCare and at regional hospitals throughout Kentucky ÔÇö like the Medical Center at Bowling Green.

ÔÇ£Advances in precision medicine offer more hope for patients than ever before, and increased access to molecular tumor board review means more patients across Kentucky can get access to the latest cancer treatments,ÔÇØ said Jill Kolesar, Pharm.D., a professor in UKÔÇÖs College of Pharmacy and co-director of MarkeyÔÇÖs Molecular Tumor Board.

Through MarkeyÔÇÖs Research Network, Simpson also enrolled in a new clinical trial led by Kolesar, which will examine the impact molecular tumor board review has on cancer patient outcomes for people with late-stage lung cancer in rural Kentucky.

With Kentucky leading the nation in lung cancer incidence and mortality, the results will provide an understanding of the direct impact that tumor board review can have.

World-class treatment close to home:

For patients like Simpson, it means confidence that they are getting the best available cancer care without having to leave the state.

ÔÇ£I never even had to leave Bowling Green for an appointment, and IÔÇÖm extremely thankful for that,ÔÇØ Simpson said. ÔÇ£At The Medical Center at Bowling Green, I knew I was getting the same care here that IÔÇÖd get in Nashville, or Lexington, or any of the nationÔÇÖs top cancer centers.ÔÇØ

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link